(Q30204573)

English

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

scientific article

Statements

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial (English)
1 reference
Michelle Dickey
1 reference
Paul Spearman
1 reference
Edwin Anderson
1 reference
Irene Graham
1 reference
Brian Mangal
1 reference
Sonnie Kim
1 reference
Jenifer Whitaker
1 reference
William Emery
1 reference
Allison Beck
1 reference
Kathy Stephens
1 reference
Brooke Hartwell
1 reference
Melinda Ogilvie
1 reference
Nayoka Rimann
1 reference
Eileen Osinski
1 reference
Ellen Destefano
1 reference
Theda Gajadhar
1 reference
Amanda Strudwick
1 reference
Ling Yue
1 reference
Dongli Wang
1 reference
Carl Ying
1 reference
Amy Cline
1 reference
Tara Foltz
1 reference
Nancy Wagner
1 reference
Geraldine Dull
1 reference
Thomas Pacatte
1 reference
Barbara Taggart
1 reference
Valerie Johnson
1 reference
Logan Haller
1 reference
Candi Looney
1 reference
Shixiong Li
1 reference
Megan May
1 reference
Bridgette Myers
1 reference
Rachel May
1 reference
Lawanda Parker
1 reference
Nertaissa Cochran
1 reference
Donna Bowen
1 reference
Michelle Bell
1 reference
Jeffery Scoggins
1 reference
Angela Burns
1 reference
Claire Stablein
1 reference
Mark Wolff
1 reference
Bernadette Jolles
1 reference
Brenda Leung
1 reference
Linda Lambert
1 reference
Shy Shorer
1 reference
Wendy Buchanan
1 reference
Suzanne Murray
1 reference
Soju Chang
1 reference
Richard Gorman
1 reference
18 November 2014
1 reference
1
1 reference
3
1 reference
ofu102
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit